Skip to main content
. 2022 Feb 16;13:843587. doi: 10.3389/fmicb.2022.843587

Table 2.

Approved direct acting antiviral drugs against SARS-CoV-2.

Antiviral drug Drug target Delivery References
Molnupiravir
(MK-4482/EIDD-2801)		 Virus RdRp Oral Jayk Bernal et al., 2021
Nirmatrelvir
(PF-07321332)		 Virus main protease Oral Owen et al., 2021
Remdesivir
(GS-5734)		 Virus RdRp Intravenous Wang et al., 2020; WHO Solidarity Trial Consortium, 2021